Kidswell Bio Corporation

4584.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents¥2,995,435¥2,231,411¥1,067,162¥1,160,934
Short-Term Investments¥0¥0¥0¥0
Receivables¥1,317,234¥881,407¥1,088,766¥488,109
Inventory¥1,475,092¥875,654¥635,315¥988,814
Other Curr. Assets¥76,388¥188,252¥72,419¥153,706
Total Curr. Assets¥6,700,570¥4,924,221¥3,697,155¥3,294,940
Property Plant & Equip (Net)¥1,187¥1,320¥1,476¥1,641
Goodwill¥0¥0¥0¥0
Intangibles¥763¥1,530¥2,297¥3,064
Long-Term Investments¥283,137¥138,218¥173,218¥154,672
Tax Assets¥0¥0-¥173,218-¥172,000
Other NC Assets¥22,839¥20,259¥193,836¥188,017
Total NC Assets¥307,926¥161,327¥197,609¥175,394
Other Assets¥0¥2¥1¥2
Total Assets¥7,008,496¥5,085,550¥3,894,765¥3,470,336
Liabilities
Payables¥226,977¥85,140¥155,563¥45,479
Short-Term Debt¥657,040¥737,040¥375,000¥75,000
Tax Payable¥0¥39,439¥32,680¥37,832
Deferred Revenue¥2,970,000¥1,117,774¥0¥982,485
Other Curr. Liab.¥320,600¥395,834¥492,596-¥29,628
Total Curr. Liab.¥4,318,862¥2,375,227¥1,055,839¥1,111,168
LT Debt¥1,180,920¥1,837,960¥1,575,000¥625,000
Deferred Rev, NC¥0¥0¥0¥0
Deferred Tax Liab, NC¥56,362¥0¥0¥0
Other NC Liab.¥41,373¥40,890¥30,421¥31,261
Total NC Liab.¥1,278,655¥1,878,850¥1,605,421¥656,261
Other Liabilities¥0-¥1¥0¥0
Cap. Leases¥0¥0¥0¥0
Total Liabilities¥5,597,517¥4,254,076¥2,661,260¥1,767,429
Equity
Pref Stock¥0¥0¥0¥0
Common Stock¥2,317,578¥2,036,724¥1,509,497¥1,421,212
Retained Earnings-¥12,730,223-¥12,709,082-¥11,287,004-¥10,629,570
AOCI¥200,516¥161,581¥195,987¥183,000
Other Equity¥0¥0¥195,987¥1
Total Equity¥1,410,977¥831,474¥1,233,505¥1,702,907
Supplemental Information
Minority Interest¥0¥0¥0¥0
Total Liab. & Tot. Equity¥7,008,496¥5,085,550¥3,894,765¥3,470,336
Net Debt-¥1,157,475¥343,589¥882,838-¥460,934
Kidswell Bio Corporation (4584.T) Financial Statements & Key Stats | AlphaPilot